Evotec Se Stock Debt To Equity
| EVOTF Stock | USD 6.77 0.00 0.00% |
Evotec SE fundamentals help investors to digest information that contributes to Evotec SE's financial success or failures. It also enables traders to predict the movement of Evotec Pink Sheet. The fundamental analysis module provides a way to measure Evotec SE's intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to Evotec SE pink sheet.
Evotec |
Evotec SE Company Debt To Equity Analysis
Evotec SE's Debt to Equity is calculated by dividing the Total Debt of a company by its Equity. If the debt exceeds equity of a company, then the creditors have more stakes in a firm than the stockholders. In other words, Debt to Equity ratio provides analysts with insights about composition of both equity and debt, and its influence on the valuation of the company.
Current Evotec SE Debt To Equity | 0.38 % |
Most of Evotec SE's fundamental indicators, such as Debt To Equity, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Evotec SE is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
High Debt to Equity ratio typically indicates that a firm has been borrowing aggressively to finance its growth and as a result may experience a burden of additional interest expense. This may reduce earnings or future growth. On the other hand a small D/E ratio may indicate that a company is not taking enough advantage from financial leverage. Debt to Equity ratio measures how the company is leveraging borrowing against the capital invested by the owners.
| Competition |
According to the company disclosure, Evotec SE has a Debt To Equity of 0.378%. This is 99.29% lower than that of the Healthcare sector and significantly higher than that of the Drug Manufacturers—Specialty & Generic industry. The debt to equity for all United States stocks is 99.22% higher than that of the company.
Evotec Debt To Equity Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Evotec SE's direct or indirect competition against its Debt To Equity to detect undervalued stocks with similar characteristics or determine the pink sheets which would be a good addition to a portfolio. Peer analysis of Evotec SE could also be used in its relative valuation, which is a method of valuing Evotec SE by comparing valuation metrics of similar companies.Evotec SE is currently under evaluation in debt to equity category among its peers.
Evotec Fundamentals
| Return On Equity | -0.16 | |||
| Return On Asset | -0.0012 | |||
| Profit Margin | (0.26) % | |||
| Operating Margin | (0.01) % | |||
| Current Valuation | 2.68 B | |||
| Shares Outstanding | 176.95 M | |||
| Shares Owned By Insiders | 9.86 % | |||
| Shares Owned By Institutions | 66.12 % | |||
| Price To Earning | 347.66 X | |||
| Price To Book | 2.28 X | |||
| Price To Sales | 4.35 X | |||
| Revenue | 618.03 M | |||
| Gross Profit | 151.54 M | |||
| EBITDA | 316.63 M | |||
| Net Income | 215.51 M | |||
| Cash And Equivalents | 887.88 M | |||
| Cash Per Share | 5.03 X | |||
| Total Debt | 326.34 M | |||
| Debt To Equity | 0.38 % | |||
| Current Ratio | 3.57 X | |||
| Book Value Per Share | 6.95 X | |||
| Cash Flow From Operations | 122.24 M | |||
| Earnings Per Share | 0.04 X | |||
| Number Of Employees | 4.71 K | |||
| Beta | 1.01 | |||
| Market Capitalization | 4.14 B | |||
| Total Asset | 2.24 B | |||
| Retained Earnings | (618.9 M) | |||
| Working Capital | 42.51 M | |||
| Current Asset | 68.96 M | |||
| Current Liabilities | 26.45 M | |||
| Z Score | 7.2 | |||
| Net Asset | 2.24 B |
About Evotec SE Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze Evotec SE's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Evotec SE using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Evotec SE based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Currently Active Assets on Macroaxis
Other Information on Investing in Evotec Pink Sheet
Evotec SE financial ratios help investors to determine whether Evotec Pink Sheet is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Evotec with respect to the benefits of owning Evotec SE security.